GRI

Teva Pharmaceuticals Europe B.V. | Teva Pharmaceutical Industries Ltd

Enforcement Competition Monetary penalty
Date: 31st Oct, 2024 Source: European Commission Country: European Union Original Source

Brief

The European Commission imposed a fine of €462.6 million on Teva Pharmaceutical Industries for abusing its dominant position in the European Union market for its multiple sclerosis drug, Copaxone. The sanction was due to Teva's strategic misuse of patent laws to delay competition and a targeted disparagement campaign against a competitor, impacting treatment choice and public health costs.

This content is restricted.

Highlights content goes here...

This content is restricted.

European Commission

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
Related Documents
Ryan Squillante
Date: 5th Sep, 2025 Source: US Securities and Exchange Commission Country: USA
Enforcement Corporate Finance & M&A Sanctions & Fines
Daryl F. Heller; Prestige Investment Group, LLC; Paramount Management Group, LLC
Date: 3rd Sep, 2025 Source: US Securities and Exchange Commission Country: USA
Enforcement Corporate Finance & M&A Sanctions & Fines
Calvin Guess; Marcus Ligon; 5 Fruits Enterprises LLC
Date: 5th Sep, 2025 Source: US Securities and Exchange Commission Country: USA
Enforcement Corporate Finance & M&A Sanctions & Fines

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales